PACAP27 Headache Properties in Migraine Without Aura Patients

See also
Status	Clinical Trial	Phase
Recruiting	`NCT02202486` - Investigation of the Blood-brain and Blood-dura Barrier Durin Migraine Attacks Using MRI	N/A
Completed	`NCT01687660` - Acupuncture for Migraine Prophylaxis	N/A
Completed	`NCT00363532` - Functional MRI (fMRI) in CGRP Induced Migraine	N/A
Completed	`NCT00123201` - Study to Evaluate the Efficacy and Safety of Dronabinol Metered Dose Inhaler (MDI) in Acute Treatment of Migraine Headache	Phase 2
Completed	`NCT04406649` - A Study to Evaluate the Safety of STS101 in the Acute Treatment of Migraine	Phase 3
Completed	`NCT03874832` - A Phase I Study to Study the PK and Safety of Single Doses of STS101, DHE Injection and Nasal Spray in Healthy Subjects	Phase 1
Recruiting	`NCT05565001` - The Involvement of ATP Sensitive Potassium Channel in Migraine Aura and Migraine Pain.	N/A
Completed	`NCT04533568` - Ibuprofen in Migraine Patients	Phase 4
Recruiting	`NCT06459635` - Migraine Attack Pain Phase Prediction Study
Recruiting	`NCT05416476` - Anisodine Hydrobromide For The Preventive Treatment Of Episodic Migraine	Phase 3
Completed	`NCT04636359` - Study the Effect of Acupuncture on Migraine Patient Without Aura Via Functional Magnetic Resonance Imaging.	N/A
Completed	`NCT00534560` - Dose Ranging Study of the Efficacy and Tolerability of Tonabersat in the Prophylaxis of Migraine Headache	Phase 2
Terminated	`NCT04936061` - Transnasal Cooling for Migraine	N/A
Recruiting	`NCT05281770` - Monoclonal CGRP Antibodies for Migraine Prevention - a Nationwide Real Life Study
Completed	`NCT00380263` - PACAP38´s (Pituitary Adenylate Cyclase-Activating Polypeptide) Headache Inducing Characteristics and Effects on the Cerebral Blood Flow	N/A
Completed	`NCT00334178` - Evaluation of the Efficacy and Safety of Laxymig® as Prophylactic Treatment in Patients With Migraine	Phase 3
Recruiting	`NCT06051604` - Mi-Helper Transnasal Cooling for Acute Treatment of Migraine	N/A
Recruiting	`NCT06414044` - Italian Real-life obServational Study on the effecTiveness, sAfety and Tolerability of Atogepant in Migraine Patients
Completed	`NCT03472378` - Can DFN-15 Terminate Migraine With Allodynia?	Phase 2
Recruiting	`NCT05211154` - Evaluation of the Efficacy of Diclofenac Potassium and Rimegepant for the Acute Treatment of Migraine	Phase 4

NCT number	NCT03471039
Study type	Interventional
Source	Danish Headache Center
Contact
Status	Completed
Phase	N/A
Start date	August 30, 2017
Completion date	September 30, 2018

PACAP27 Headache Properties in Migraine Without Aura Patients

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms